| __timestamp | Takeda Pharmaceutical Company Limited | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1256834000000 | 3669400000 |
| Thursday, January 1, 2015 | 1271973000000 | 4382200000 |
| Friday, January 1, 2016 | 1173296000000 | 4998500000 |
| Sunday, January 1, 2017 | 1274610000000 | 4976200000 |
| Monday, January 1, 2018 | 1437534000000 | 4572000000 |
| Tuesday, January 1, 2019 | 2201424000000 | 4444200000 |
| Wednesday, January 1, 2020 | 2203504000000 | 3796700000 |
| Friday, January 1, 2021 | 2462160000000 | 5575500000 |
| Saturday, January 1, 2022 | 2783406000000 | 6497000000 |
| Sunday, January 1, 2023 | 2832257000000 | 6438600000 |
| Monday, January 1, 2024 | 2832257000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, Takeda Pharmaceutical Company Limited and Viatris Inc. stand as titans, each with a unique trajectory in gross profit performance. Over the past decade, Takeda has demonstrated a robust growth pattern, with its gross profit surging by approximately 125% from 2014 to 2023. This growth is highlighted by a significant leap in 2019, where profits nearly doubled, marking a pivotal year for the company.
Conversely, Viatris Inc. has shown a more modest yet steady increase, with gross profits rising by about 75% over the same period. Notably, 2022 was a standout year for Viatris, achieving its highest recorded profit, a testament to its strategic market maneuvers.
While Takeda's trajectory is marked by rapid expansion, Viatris's consistent growth underscores its resilience in a competitive market. Missing data for 2024 suggests an evolving narrative, inviting further scrutiny.
Who Generates Higher Gross Profit? AbbVie Inc. or Viatris Inc.
Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Takeda Pharmaceutical Company Limited and Incyte Corporation: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Takeda Pharmaceutical Company Limited vs Grifols, S.A.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Arrowhead Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited vs Vericel Corporation: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends
Viatris Inc. and Pharming Group N.V.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Viatris Inc. and Taro Pharmaceutical Industries Ltd.
Gross Profit Analysis: Comparing Viatris Inc. and Travere Therapeutics, Inc.